05:44 PM EDT, 07/16/2024 (MT Newswires) -- Anish Patel, COO, on July 12, 2024, sold 50,000 shares in Enliven Therapeutics ( ELVN ) for $1,252,826. Following the Form 4 filing with the SEC, Patel has control over a total of 344,027 shares of the company, with 344,027 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1672619/000141588924019600/xslF345X03/form4-07162024_090759.xml

Price: 24.58, Change: -0.07, Percent Change: -0.28